Filing Details

Accession Number:
0001181431-13-040868
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-19 18:39:44
Reporting Period:
2013-07-17
Filing Date:
2013-07-19
Accepted Time:
2013-07-19 18:39:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1018394 G Alan Spoon C/O Polaris Venture Partners
1000 Winter Street
Waltham MA 02451
No No Yes Yes
1117003 Terrance Mcguire C/O Polaris Venture Partners
1000 Winter Street
Waltham MA 02451
No No Yes Yes
1157864 Polaris Venture Partners Iv Lp C/O Polaris Venture Partners
1000 Winter Street
Waltham MA 02451
No No Yes Yes
1170720 Polaris Venture Partners Entrepreneurs Fund Iv Lp C/O Polaris Venture Partners
1000 Winter Street
Waltham MA 02451
No No Yes Yes
1295438 Polaris Venture Management Co Iv Llc C/O Polaris Venture Partners
1000 Winter Street
Waltham MA 02451
No No Yes Yes
1295676 A Jonathan Flint C/O Polaris Venture Partners
1000 Winter Street
Waltham MA 02451
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-07-17 2,273 $4.80 57,586 No 4 S Indirect See Footnote
Common Stock Disposition 2013-07-17 120,664 $4.80 3,090,769 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.80 to $5.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
  2. The reportable securities are owned directly by Polaris Venture Partners Entrepreneurs' Fund IV, L.P. ("PVPE IV"). Polaris Venture Management Co. IV, L.L.C. ("PVM IV") is the general partner of PVPE IV. PVM IV disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM IV is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. Each of Jonathan A. Flint ("Flint"), Terrance G. McGuire ("McGuire") and Alan G. Spoon ("Spoon") are the managing members of PVM IV. Each of Flint, McGuire and Spoon disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein.
  3. The reportable securities are owned directly by Polaris Venture Partners IV, L.P. (" PVP IV"). PVM IV is the general partner of PVP IV. PVM IV disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM IV is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. Each of Flint, McGuire and Spoon are the managing members of PVM IV. Each of Flint, McGuire and Spoon disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein.